Related Experiment Video
Updated: Sep 4, 2026

The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice
Published on: April 2, 2014
Effects of toluene inhalation on pulmonary host defenses of mice
Abstract:
The potential hazards of exposure to vapor-phase toluene on pulmonary host defenses were evaluated. Mice exposed to concentrations ranging from 2.5-500 ppm, including the threshold limit value level of 100 ppm, exhibited increased susceptibility to respiratory infection with Streptococcus zooepidemicus. The no-measurable-effect level for single, as well as for 5 exposures was 1 ppm. Significantly decreased pulmonary bactericidal activity was observed after single exposures to 500, 250, 100 and 2.5 ppm toluene, and after 5 daily 3-h exposures to 1.0 ppm of toluene. A 20-exposure study with toluene at 1 ppm produced no changes in either of the 2 assays.
Insights
Exposure to toluene vapor, even at low levels, can harm lung defenses and increase infection risk. Even 1 ppm of toluene impaired mice
Area of Science:
- Toxicology
- Immunology
- Occupational Health
Background:
- Toluene is a common industrial solvent with potential health risks.
- Understanding toluene's impact on respiratory health is crucial for workplace safety.
Purpose of the Study:
- To evaluate the effects of vapor-phase toluene exposure on pulmonary host defenses in mice.
- To determine the no-measurable-effect level (NMEL) for toluene exposure on lung immunity.
Main Methods:
- Mice were exposed to various concentrations of toluene vapor (2.5-500 ppm).
- Pulmonary bactericidal activity and susceptibility to Streptococcus zooepidemicus infection were assessed.
- Single and multiple exposure scenarios (5 and 20 exposures) were investigated.
Main Results:
- Toluene exposure increased susceptibility to respiratory infection.
- Significantly decreased pulmonary bactericidal activity was observed at concentrations as low as 2.5 ppm after single exposure.
- A no-measurable-effect level of 1 ppm was established for single and 5 exposures.
- 20 exposures to 1 ppm toluene did not affect pulmonary defenses.
Conclusions:
- Vapor-phase toluene exposure poses a hazard to pulmonary host defenses.
- Even low-level toluene exposure can impair the lungs' ability to fight infection.
- Occupational exposure limits should consider the potential for reduced lung immunity.

